Resveratrol ameliorates spatial learning memory impairment induced by Aβ1–42 in rats

Neuroscience

Volumn 344, Issue , 2017, Pages 39-47

  Wang, Rui ^a   Zhang, Yu ^a   Li, Jianguo ^a   Zhang, Ce ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

amyloid beta peptide; CREB; learning and memory; LTP; resveratrol; SIRT1

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; RESVERATROL; SIRTUIN 1; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); NEUROPROTECTIVE AGENT; NOOTROPIC AGENT; PEPTIDE FRAGMENT; SIRT1 PROTEIN, RAT; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPAL CA1 REGION; LONG TERM POTENTIATION; MALE; MAZE TEST; MEMORY DISORDER; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPATIAL LEARNING; SPATIAL LEARNING MEMORY IMPAIRMENT; ANIMAL; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; LEARNING DISORDERS; MEMORY DISORDERS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RANDOMIZATION; SPATIAL MEMORY; SPRAGUE DAWLEY RAT; TIME FACTOR; WESTERN BLOTTING;

AMYLOID BETA-PEPTIDES; ANIMALS; BLOTTING, WESTERN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; LEARNING DISORDERS; LONG-TERM POTENTIATION; MALE; MEMORY DISORDERS; NEUROPROTECTIVE AGENTS; NOOTROPIC AGENTS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; SIRTUIN 1; SPATIAL LEARNING; SPATIAL MEMORY; STILBENES; TIME FACTORS;

EID: 85009154389     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2016.08.051     Document Type: Article

References (48)

1. Albani, D., Polito, L., Batelli, S., De Mauro, S., Fracasso, C., Martelli, G., Colombo, L., Manzoni, C., Salmona, M., Caccia, S., Negro, A., Forloni, G., The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1–42) peptide. J Neurochem 110 (2009), 1445–1456.
2. Baur, J.A., Sinclair, D.A., Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5 (2006), 493–506.
3. Chew, E.Y., Clemons, T.E., Agron, E., Launer, L.J., Grodstein, F., Bernstein, P.S., Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function: The areds2 randomized clinical trial. JAMA 314 (2015), 791–801.
4. Debanne, D., Guerineau, N.C., Gahwiler, B.H., Thompson, S.M., Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release. J Physiol 491:Pt 1 (1996), 163–176.
5. Dysken, M.W., Sano, M., Asthana, S., Vertrees, J.E., Pallaki, M., Llorente, M., Love, S., Schellenberg, G.D., McCarten, J.R., Malphurs, J., Prieto, S., Chen, P., Loreck, D.J., Trapp, G., Bakshi, R.S., Mintzer, J.E., Heidebrink, J.L., Vidal-Cardona, A., Arroyo, L.M., Cruz, A.R., Zachariah, S., Kowall, N.W., Chopra, M.P., Craft, S., Thielke, S., Turvey, C.L., Woodman, C., Monnell, K.A., Gordon, K., Tomaska, J., Segal, Y., Peduzzi, P.N., Guarino, P.D., Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 311 (2014), 33–44.
6. Farina, N., Isaac, M.G., Clark, A.R., Rusted, J., Tabet, N., Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst Rev, 11, 2012, CD002854.
7. Feldman, H.H., Doody, R.S., Kivipelto, M., Sparks, D.L., Waters, D.D., Jones, R.W., Schwam, E., Schindler, R., Hey-Hadavi, J., DeMicco, D.A., Breazna, A., LEADe Investigators. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology 74 (2010), 956–964.
8. Feng, X., Liang, N., Zhu, D., Gao, Q., Peng, L., Dong, H., Yue, Q., Liu, H., Bao, L., Zhang, J., Hao, J., Gao, Y., Yu, X., Sun, J., Resveratrol inhibits beta-amyloid-induced neuronal apoptosis through regulation of SIRT1-ROCK1 signaling pathway. PLoS One, 8, 2013, e59888.
9. Feng, Y., Wang, X.P., Yang, S.G., Wang, Y.J., Zhang, X., Du, X.T., Sun, X.X., Zhao, M., Huang, L., Liu, R.T., Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology 30 (2009), 986–995.
10. Fusco, S., Ripoli, C., Podda, M.V., Ranieri, S.C., Leone, L., Toietta, G., McBurney, M.W., Schutz, G., Riccio, A., Grassi, C., Galeotti, T., Pani, G., A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction. Proc Natl Acad Sci USA 109 (2012), 621–626.
11. Gao, J., Wang, W.Y., Mao, Y.W., Graff, J., Guan, J.S., Pan, L., Mak, G., Kim, D., Su, S.C., Tsai, L.H., A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466 (2010), 1105–1109.
12. Granzotto, A., Zatta, P., Resveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Abeta and Abeta-metal complexes toxicity. PLoS One, 6, 2011, e21565.
13. Haass, C., Selkoe, D.J., Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8 (2007), 101–112.
14. Han, Y.S., Zheng, W.H., Bastianetto, S., Chabot, J.G., Quirion, R., Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol 141 (2004), 997–1005.
15. Hu, J., Lin, T., Gao, Y., Xu, J., Jiang, C., Wang, G., Bu, G., Xu, H., Chen, H., Zhang, Y.W., The resveratrol trimer miyabenol C inhibits beta-secretase activity and beta-amyloid generation. PLoS One, 10, 2015, e0115973.
16. Jang, J.H., Surh, Y.J., Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. Free Radic Biol Med 34 (2003), 1100–1110.
17. Julien, C., Tremblay, C., Emond, V., Lebbadi, M., Salem, N. Jr., Bennett, D.A., Calon, F., Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 68 (2009), 48–58.
18. Klein, W.L., Stine, W.B. Jr., Teplow, D.B., Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol Aging 25 (2004), 569–580.
19. Kwon, K.J., Kim, H.J., Shin, C.Y., Han, S.H., Melatonin potentiates the neuroprotective properties of resveratrol against beta-amyloid-induced neurodegeneration by modulating amp-activated protein kinase pathways. J Clin Neurol 6 (2010), 127–137.
20. Lesne, S., Koh, M.T., Kotilinek, L., Kayed, R., Glabe, C.G., Yang, A., Gallagher, M., Ashe, K.H., A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440 (2006), 352–357.
21. Li, Z., Pang, L., Fang, F., Zhang, G., Zhang, J., Xie, M., Wang, L., Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2. Brain Res 1450 (2012), 116–124.
22. Lu, C., Guo, Y., Li, J., Yao, M., Liao, Q., Xie, Z., Li, X., Design, synthesis, and evaluation of resveratrol derivatives as Ass((1)-(4)(2)) aggregation inhibitors, antioxidants, and neuroprotective agents. Bioorg Med Chem Lett 22 (2012), 7683–7687.
23. Luchsinger, J.A., Tang, M.X., Siddiqui, M., Shea, S., Mayeux, R., Alcohol intake and risk of dementia. J Am Geriatr Soc 52 (2004), 540–546.
24. Luo, Y., Smith, J.V., Paramasivam, V., Burdick, A., Curry, K.J., Buford, J.P., Khan, I., Netzer, W.J., Xu, H., Butko, P., Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci USA 99 (2002), 12197–12202.
25. Ma, T., Hoeffer, C.A., Wong, H., Massaad, C.A., Zhou, P., Iadecola, C., Murphy, M.P., Pautler, R.G., Klann, E., Amyloid beta-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide. J Neurosci 31 (2011), 5589–5595.
26. Michan, S., Li, Y., Chou, M.M., Parrella, E., Ge, H., Long, J.M., Allard, J.S., Lewis, K., Miller, M., Xu, W., Mervis, R.F., Chen, J., Guerin, K.I., Smith, L.E., McBurney, M.W., Sinclair, D.A., Baudry, M., de Cabo, R., Longo, V.D., SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci 30 (2010), 9695–9707.
27. Morris, R., Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11 (1984), 47–60.
28. Noriega, L.G., Feige, J.N., Canto, C., Yamamoto, H., Yu, J., Herman, M.A., Mataki, C., Kahn, B.B., Auwerx, J., CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability. EMBO Rep 12 (2011), 1069–1076.
29. Nunomura, A., Castellani, R.J., Zhu, X., Moreira, P.I., Perry, G., Smith, M.A., Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 65 (2006), 631–641.
30. Orgogozo, J.M., Dartigues, J.F., Lafont, S., Letenneur, L., Commenges, D., Salamon, R., Renaud, S., Breteler, M.B., Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 153 (1997), 185–192.
31. Puzzo, D., Staniszewski, A., Deng, S.X., Privitera, L., Leznik, E., Liu, S., Zhang, H., Feng, Y., Palmeri, A., Landry, D.W., Arancio, O., Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model. J Neurosci 29 (2009), 8075–8086.
32. Querfurth, H.W., LaFerla, F.M., Alzheimer's disease. N Engl J Med 362 (2010), 329–344.
33. Sano, M., Bell, K.L., Galasko, D., Galvin, J.E., Thomas, R.G., van Dyck, C.H., Aisen, P.S., A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology 77 (2011), 556–563.
34. Scuderi, C., Stecca, C., Bronzuoli, M.R., Rotili, D., Valente, S., Mai, A., Steardo, L., Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer's disease. Front Pharmacol, 5, 2014, 89.
35. Selkoe, D.J., Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81 (2001), 741–766.
36. Shipton, O.A., Leitz, J.R., Dworzak, J., Acton, C.E., Tunbridge, E.M., Denk, F., Dawson, H.N., Vitek, M.P., Wade-Martins, R., Paulsen, O., Vargas-Caballero, M., Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation. J Neurosci 31 (2011), 1688–1692.
37. Tanzi, R.E., Bertram, L., Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120 (2005), 545–555.
38. Tao, W., Chen, Q., Zhou, W., Wang, Y., Wang, L., Zhang, Z., Persistent inflammation-induced up-regulation of brain-derived neurotrophic factor (BDNF) promotes synaptic delivery of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluA1 subunits in descending pain modulatory circuits. J Biol Chem 289 (2014), 22196–22204.
39. Tao, X., Finkbeiner, S., Arnold, D.B., Shaywitz, A.J., Greenberg, M.E., Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20 (1998), 709–726.
40. Vorhees, C.V., Williams, M.T., Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1 (2006), 848–858.
41. Walsh, D.M., Selkoe, D.J., A beta oligomers – a decade of discovery. J Neurochem 101 (2007), 1172–1184.
42. Wang, J., Ho, L., Zhao, W., Ono, K., Rosensweig, C., Chen, L., Humala, N., Teplow, D.B., Pasinetti, G.M., Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci 28 (2008), 6388–6392.
43. Wang, J., Ho, L., Zhao, Z., Seror, I., Humala, N., Dickstein, D.L., Thiyagarajan, M., Percival, S.S., Talcott, S.T., Pasinetti, G.M., Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J 20 (2006), 2313–2320.
44. Wang, X.H., Li, L., Holscher, C., Pan, Y.F., Chen, X.R., Qi, J.S., Val8-glucagon-like peptide-1 protects against Abeta1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats. Neuroscience 170 (2010), 1239–1248.
45. Wu, J.W., Wang, J.J., Chen, J.B., Huang, Y.L., Wang, H., Liu, G.H., Li, L.F., Kang, M., Wang, X.G., Cai, H.H., Resveratrol could reverse the expression of SIRT1 and MMP-1 in vitro. Genet Mol Res 14 (2015), 12386–12393.
46. Yamamoto-Sasaki, M., Ozawa, H., Saito, T., Rosler, M., Riederer, P., Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res 824 (1999), 300–303.
47. Zhang, J., Feng, X., Wu, J., Xu, H., Li, G., Zhu, D., Yue, Q., Liu, H., Zhang, Y., Sun, D., Wang, H., Sun, J., Neuroprotective effects of resveratrol on damages of mouse cortical neurons induced by beta-amyloid through activation of SIRT1/Akt1 pathway. BioFactors 40 (2014), 258–267.
48. Zhao, W., Zhao, J., Hou, M., Wang, Y., Zhang, Y., Zhao, X., Zhang, C., Guo, D., HuR and TIA1/TIAL1 are involved in regulation of alternative splicing of SIRT1 pre-mRNA. Int J Mol Sci 15 (2014), 2946–2958.